Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
JANAK MEHTA AWARD WINNING PAPER  

 Article Access Statistics
    Viewed5635    
    Printed224    
    Emailed14    
    PDF Downloaded627    
    Comments [Add]    
    Cited by others 5    

Recommend this journal

Effect of prophylactic amiodarone in patients with rheumatic valve disease undergoing valve replacement surgery


1 Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research, Kolkata, India
2 Department of Cardiac Anaesthesia, Institute of Post Graduate Medical Education and Research, Kolkata, India

Correspondence Address:
Chaitali Sen Dasgupta
Department of Cardiac Anaesthesia, Institute of Post Graduate Medical Education and Research, Kolkata
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.83986

Rights and Permissions

Year : 2011  |  Volume : 14  |  Issue : 3  |  Page : 176-182

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (358 KB)
Email article
Print Article
Add to My List
The study was carried out to evaluate the effect of prophylactic single-dose intravenous amiodarone in patients undergoing valve replacement surgery. Maintenance of sinus rhythm is better than maintenance of fixed ventricular rate in atrial fibrillation (AF) especially in the presence of irritable left or right atrium because of enlargement. Fifty-six patients with valvular heart disease with or without AF were randomly divided into two groups. Group I or the amiodarone group (n=28) received amiodarone (3 mg/kg in 100 ml normal saline) and group II or the control group received same volume of normal saline. The standardized protocol for cardiopulmonary bypass was maintained for all the patients. AF occurred in 7.14% patients in group I, and in group II, 28.57% (P=0.035); ventricular tachycardia/fibrillation was observed in 21.43% patients in group I and 46.43% patients in group II (P=0.089) after release of aortic clamp. Most of the patients in group I (92.86%) maintained sinus rhythm without cardioversion or defibrillation after release of aortic cross clamp (P=0.002). Defibrillation or cardio version was needed in 7.14% patients in group I and 28.57% patients in group II (P=0.078). A single prophylactic intraoperative dose of intravenous amiodarone decreased post bypass arrhythmia in this study in comparison to the control group. Single dose of intraoperative amiodarone may be used to decrease postoperative arrhythmia in open heart surgery.






[FULL TEXT] [PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 JANAK MEHTA AWARD WINNING PAPER
 




1 Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research, Kolkata, India
2 Department of Cardiac Anaesthesia, Institute of Post Graduate Medical Education and Research, Kolkata, India

Correspondence Address:
Chaitali Sen Dasgupta
Department of Cardiac Anaesthesia, Institute of Post Graduate Medical Education and Research, Kolkata
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.83986

Rights and Permissions

The study was carried out to evaluate the effect of prophylactic single-dose intravenous amiodarone in patients undergoing valve replacement surgery. Maintenance of sinus rhythm is better than maintenance of fixed ventricular rate in atrial fibrillation (AF) especially in the presence of irritable left or right atrium because of enlargement. Fifty-six patients with valvular heart disease with or without AF were randomly divided into two groups. Group I or the amiodarone group (n=28) received amiodarone (3 mg/kg in 100 ml normal saline) and group II or the control group received same volume of normal saline. The standardized protocol for cardiopulmonary bypass was maintained for all the patients. AF occurred in 7.14% patients in group I, and in group II, 28.57% (P=0.035); ventricular tachycardia/fibrillation was observed in 21.43% patients in group I and 46.43% patients in group II (P=0.089) after release of aortic clamp. Most of the patients in group I (92.86%) maintained sinus rhythm without cardioversion or defibrillation after release of aortic cross clamp (P=0.002). Defibrillation or cardio version was needed in 7.14% patients in group I and 28.57% patients in group II (P=0.078). A single prophylactic intraoperative dose of intravenous amiodarone decreased post bypass arrhythmia in this study in comparison to the control group. Single dose of intraoperative amiodarone may be used to decrease postoperative arrhythmia in open heart surgery.






[FULL TEXT] [PDF]*


        
Print this article     Email this article